
USD
+$0.00
(+0.00%
)At Close (As of Dec 17, 2025)
$3.36B
Market Cap
-
P/E Ratio
-0.04
EPS
$11.14
52 Week High
$5.51
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Total Assets | $785M |
| Total Current Assets | $505M |
| Cash And Cash Equivalents At Carrying Value | $214M |
| Cash And Short Term Investments | $214M |
| Inventory | $119M |
| Current Net Receivables | $101M |
| Total Non Current Assets | $280M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $17M |
| Intangible Assets Excluding Goodwill | $17M |
| Goodwill | $198M |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $36M |
| Other Current Assets | $35M |
| Other Non Current Assets | - |
| Total Liabilities | $591M |
| Total Current Liabilities | $149M |
| Current Accounts Payable | $13M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $8.5M |
| Total Non Current Liabilities | $442M |
| Capital Lease Obligations | $54M |
| Long Term Debt | $390M |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $444M |
| Other Current Liabilities | $109M |
| Other Non Current Liabilities | $7.1M |
| Total Shareholder Equity | $194M |
| Treasury Stock | - |
| Retained Earnings | -$2.7B |
| Common Stock | $2.9M |
| Common Stock Shares Outstanding | $304M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$34M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $8.5M |
| Capital Expenditures | $3.6M |
| Change In Receivables | - |
| Change In Inventory | -$74M |
| Profit Loss | - |
| Cashflow From Investment | -$560K |
| Cashflow From Financing | $5.1M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$56M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Amicus Therapeutics, Inc. (FOLD) is a prominent biopharmaceutical company based in Philadelphia, Pennsylvania, dedicated to developing groundbreaking therapies for rare metabolic disorders. Utilizing its proprietary enzyme replacement therapy platform, Amicus is a leader in personalized medicine, crafting tailored solutions for patients with significant unmet medical needs. The company boasts a strong pipeline focused on innovative treatments for lysosomal storage disorders, reflecting its commitment to advancing healthcare in the rare disease arena and solidifying its position as a pivotal entity within the biotechnology industry.